Journal of Fungi (Feb 2024)

Biological Activities of Secondary Metabolites from the Edible-Medicinal Macrofungi

  • Xiaoqi Sun,
  • Ying Shi,
  • Dongxiao Shi,
  • Yu Tu,
  • Ling Liu

DOI
https://doi.org/10.3390/jof10020144
Journal volume & issue
Vol. 10, no. 2
p. 144

Abstract

Read online

Macrofungi are well-known as edible-medicinal mushrooms, which belong mostly to Basidiomycota, with a few from Ascomycota. In recent years, macrofungi have been recognized as a rich resource of structurally unique secondary metabolites, demonstrating a wide range of bioactivities, including anti-tumor, antioxidant, anti-inflammatory, antimicrobial, antimalarial, neuro-protective, hypoglycemic, and hypolipidemic activities. This review highlights over 270 natural products produced by 17 families of macrofungi covering 2017 to 2023, including their structures, bioactivities, and related molecular mechanisms.

Keywords